Adicet Bio, Inc. — Director's Dealing 2019

Dec 6, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: resTORbio, Inc. (TORC)
CIK: 0001720580
Period of Report: 2019-12-06

Reporting Person: Schor Chen (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-06	Common Stock	A	344000	$0.00	Acquired	669000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-06	Stock Option (Right to Buy)	$1.27	A	258000	Acquired	2029-12-05	Common Stock (258000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1567363	Indirect

Footnotes

F1: The Reporting Person was issued Restricted Stock Units ("RSU"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.

F2: Represents 599,363 shares held directly by an irrevocable family trust having an independent trustee, 25,000 shares held by a revocable family trust of which the Reporting Person is the trustee, 643,000 shares held directly by an irrevocable family trust having an independent trustee, 25,000 shares held directly by a revocable trust of which the spouse is the trustee and 275,000 shares held directly by a grantor retained annuity trust of the spouse.

F3: 25% of the shares shall vest on December 6, 2020, with the remainder vesting in 36 equal monthly installments thereafter.